- Report
- October 2023
- 150 Pages
Global
From €4683EUR$4,850USD£3,965GBP
- Report
- October 2023
- 150 Pages
Global
From €4683EUR$4,850USD£3,965GBP
- Report
- October 2023
- 150 Pages
Global
From €4683EUR$4,850USD£3,965GBP
- Report
- November 2023
- 148 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- April 2024
- 135 Pages
Global
From €3764EUR$3,899USD£3,188GBP
- Report
- April 2024
- 136 Pages
Global
From €3764EUR$3,899USD£3,188GBP
- Report
- April 2024
- 137 Pages
Global
From €3764EUR$3,899USD£3,188GBP
- Report
- November 2023
- 144 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- November 2023
- 139 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- October 2023
- 139 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- October 2023
- 145 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- October 2023
- 147 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- October 2023
- 145 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- September 2023
- 145 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- January 2024
- 150 Pages
Global
From €4683EUR$4,850USD£3,965GBP
- Report
- April 2024
- 447 Pages
Global
From €3244EUR$3,360USD£2,747GBP
€4055EUR$4,200USD£3,434GBP
- Report
- May 2024
- 213 Pages
Global
From €5262EUR$5,450USD£4,456GBP
- Report
- May 2024
- 164 Pages
Global
From €5262EUR$5,450USD£4,456GBP
- Report
- May 2024
- 146 Pages
Global
From €5262EUR$5,450USD£4,456GBP
- Report
- May 2024
- 167 Pages
Global
From €5262EUR$5,450USD£4,456GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more